CalciMedica
CALC | NASDAQ
$1.19
-$0.02 (-1.65%)
At close: Nov 16, 2026, 4:00 PM ET
$1.19
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
CalciMedica Company Profile
Company profile explainedCompany Profile
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.
Key Executives
| Name | Position |
|---|---|
| A. Rachel Leheny | Chief Executive Officer & Director |
| Michael J. Dunn | President & Chief Operating Officer |
| Stephen Bardin | Chief Financial Officer |
| Anjana Rao | Co-Founder and Scientific Advisor |
| Eric W. Roberts | Chief Business Officer & Vice Chairman of the Board |
| John Dunn | General Counsel |
| Kenneth A. Stauderman | Co-Founder & Chief Scientific Officer |
| Patrick Hogan | Co-Founder and Scientific Advisor |
| Stefan Feske | Co-Founder and Scientific Advisor |
| Sudarshan Hebbar | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 16, 2026 | 8-K | Current Report |
| Oct 05, 2026 | 4 | Filing |
| Oct 05, 2026 | 4 | Filing |
| Oct 05, 2026 | 4 | Filing |
| Oct 05, 2026 | 4 | Filing |
| Oct 05, 2026 | 4 | Filing |
| Sep 30, 2026 | 8-K | Current Report |
| Sep 30, 2026 | 424B5 | Filing |
| Sep 28, 2026 | 4 | Filing |
| Sep 28, 2026 | 4 | Filing |
CalciMedica
| Country | United States |
| IPO Date | Jun 14, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | A. Rachel Leheny |
Contact Details
505 Coast Boulevard South La Jolla,
California 92037 United States
Stock Details
| Ticker Symbol | CALC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001534133 |
| CUSIP Number | 38942Q301 |
| ISIN Number | US38942Q3011 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove CALC